カタログ製品コード : C-EK11342
Human osteoprotegerin/OPG ELISA kit
| 24T | ¥55,200 | (¥2,300/T) (税別) |
| 48T | ¥69,200 | (¥1,442/T) (税別) |
| 96T | ¥78,000 | (¥813/T) (税別) |
標準納期 : 2週間 |
製品詳細
| メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
|---|---|---|---|---|---|---|
| MultiSciences | osteoprotegerin/OPG | Human | 62.50 - 4000 pg/ml | 10 μl | 血清、血漿、細胞培養上清 |
|
■保存方法 :
キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。
■構成内容 :
| 96-well polystyrene microplate coated with a monoclonal antibody against OPG |
| Human OPG Standard, lyophilized |
| OPG Detect Antibody |
| Standard Diluent |
| Streptavidin-HRP |
| Assay Buffer (10×) |
| Substrate (TMB) |
| Stop Solution |
| Washing Buffer (20×) |
| Plate Covers |
■キーワード :
Homo sapiens,Human,Tumor necrosis factor receptor superfamily member 11B,Osteoclastogenesis inhibitory factor,Osteoprotegerin,TNFRSF11B,OCIF,OPG
■ターゲット情報 :
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human OPG. The Human osteoprotegerin/OPG ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Osteoprotegerin (OPG), also known as OCIF or TNFRSF11B, is a cytokine receptor, and a member of the tumor necrosis factor (TNF) receptor superfamily. OPG can reduce the production of osteoclasts by inhibiting the differentiation of osteoclast precursors into osteoclasts and also regulates the resorption of osteoclasts in vitro and in vivo. Recombinant human OPG specifically acts on bone, increasing bone mineral density and bone volume.
Elevated OPG levels has been reported in heart diseases, in placebo effect serum responses in IBS patients and in severe mental disorders. In recent years, it has been hypothesized that OPG may be a link between bone and cardiovascular disease. It has been particularly related to the increase in cardiovascular risk in patients suffering from diabetes.
